Baker McKenzie has a highly diversified healthcare offering, with the firm instructed on behalf of major clients in public procurement and distribution platform establishment; pharmaceutical advertising, marketing and legal proceedings; and a range of sales and acquisitions of shares and portfolios in hospital groups and life science tech companies. Over the last year the practice has been instructed on an array of damages claims before the courts by international pharmaceutical firms. With extremely broad experience across multiple disciplines, practice leader Thilo Räpple is valued for his contentious and non-contentious experience. Other key names include Julia Braun, who is specialised in a variety of healthcare and life sciences transactions and financings, and Martin Altschwager, a regulatory and contract law expert.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
- ‘The team stands out for its deep sector expertise, strategic mindset, and pragmatic approach to problem-solving. What makes this practice unique is its ability to integrate legal rigor with a genuine understanding of the business context in which its clients operate.’
- ‘The individuals I work with demonstrate an exceptional blend of legal precision, commercial awareness, and emotional intelligence. They stand out from competitors for their proactivity, availability, and genuine sense of partnership.’
- ‘In depth knowledge of the field with sufficient network to support in different jurisdictions while ensuring product quality.’
- ‘Thilo Räpple is, in my opinion, the reference in this sector.’
- ‘For an asset disinvestment transaction we work with BM's pharma law and M&A teams. The level of knowledge, commitment and team spirit made a complex transaction a success. They approached the work not as legal counsellors, but as active players driving the process towards success. That is the kind of team you want to have supporting you.’
- ‘Thilo Räpple is simply one of the most knowledgeable pharma lawyers I have met in my career. I was particularly impressed by the practical knowledge of Martin Altschwager on pharma topics. I would not be surprised if he is recognised in a few years as one of the top pharma lawyers in region.’
Key clients
- Boehringer Ingelheim
- ABT Therapeutics
- CureVac
- EQT Life Sciences
- Fagron NV
- KD Pharma Group
- Mitsubishi Tanabe Pharma
- Siemens/Siemens Healthineers
Work highlights
Advised an international pharmaceutical company based in Switzerland on FSR matters.
Advised multiple international pharmaceutical companies in proceedings before social courts with regards to claims for damages from statutory health insurance funds.
Advised EQT Life Sciences on the closing of a €128m Series B2 financing round for Tubulis GmbH.
Lawyers
Hall of Fame
The lawyers at the very top of the profession, widely known and respected by peers and clients for their longstanding involvement in market-leading work.
Leading partners
The strongest partners in their field, leading on market-leading deals and endorsed by peers and clients alike.
Practice head
Thilo Räpple
Other key lawyers
Julia Braun; Martin Altschwager